Skip to main content

Table 1 Demographic and Treatment Data

From: Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains

  Site A Site B
Median/Mean age 6 yrs/7.5 yrs 6 yrs/7.5 yrs
Male 104/200 (52%) 105/200 (53%)
Caucasian 61/200 (30%) 161/200 (80%)
Medicaid 131/200 (65%) 108/200 (52%)
Penicillin/amoxicillin 178/200 (91%) 179/200 (90%)
Oral cephalosporin 8/200 (4%) 20/200 (10%)
Other/none 14/200 (7%) 1/200 (0.5%)